Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease.
about
Naproxen-induced Ca2+ movement and death in MDCK canine renal tubular cells.Novel naproxen/esomeprazole magnesium compound pellets based on acid-independent mechanism: in vitro and in vivo evaluation.Novel organogels for topical delivery of naproxen: design, physicochemical characteristics and in vitro drug permeation
P2860
Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety aspects and rational us ...... eatment of rheumatoid disease.
@en
Safety aspects and rational us ...... eatment of rheumatoid disease.
@nl
type
label
Safety aspects and rational us ...... eatment of rheumatoid disease.
@en
Safety aspects and rational us ...... eatment of rheumatoid disease.
@nl
prefLabel
Safety aspects and rational us ...... eatment of rheumatoid disease.
@en
Safety aspects and rational us ...... eatment of rheumatoid disease.
@nl
P2860
P356
P1476
Safety aspects and rational us ...... eatment of rheumatoid disease.
@en
P2093
David N Roberts
Philip B Miner
P2860
P356
10.2147/DHPS.S7329
P407
P577
2011-03-03T00:00:00Z